Global Creatinine Measurement Market, Forecast Till 2025

  • Category : Healthcare and Pharma
  • |
  • ID : 731191
  • |
  • Date : 14-Jan-19
  • |
  • No of Pages: 121
  • |
  • Publisher : Intellectual Research Partners

The Global Creatinine Measurement Market was valued at USD XX million in 2017, and is expected to grow at a CAGR of XX% by 2025 The major factors driving the growth of this market are the increasing demand for monoclonal antibodies and increasing R&D expenditure in biopharmaceuticals.

The growth of this market is mainly driven by increasing incidence of renal disorders, growing incidence of other chronic disorders impacting renal function, rising awareness and adoption of preventive healthcare approaches, implementation of favorable government initiatives to promote renal health, rapid growth in the geriatric population, and increasing number of drug development initiatives.

Factors, such as shifting preferences of healthcare professionals towards novel techniques that include the identification of renal dysfunction biomarkers, and lack of predictive value obtained by creatinine measurement techniques is expected to hamper the market growth.

Commercialization of Advanced Testing Methods in the coming forecast period will offer lucrative opportunities.

Based on the type, the market is segmented into Jaffe’s kinetic method and enzymatic method. In 2018, the Jaffe’s kinetic method segment is estimated to account for the largest share of the creatinine measurement market, as it is the oldest and most conventional method for creatinine measurement in clinical samples.

Based on end user, the creatinine measurement market is segmented into hospitals and diagnostic laboratories.

Regionally, North America dominated the market followed by Europe. Asia is expected to grow at the highest CAGR during the forecast period. This can be attributed to factors such as the growing prevalence of CKD, rising awareness about preventive healthcare, improving healthcare infrastructure.

Some of the key players operating in this market include F. Hoffmann-la Roche Ltd (Switzerland), Abbott Laboratories (US), Danaher Corporation (US), Thermo Fisher Scientific (US), Siemens Healthineers (Germany), Randox Laboratories (UK)

Key Benefits of the Report:
* Global, Regional, Country, Type, and END-USER OF MOLECULE Market Size and Forecast from 2014-2025
* Detailed market dynamics, industry outlook with market specific PESTLE, Value Chain, Supply Chain, and SWOT Analysis to better understand the market and build strategies
* Identification of key companies that can influence this market on a global and regional scale
* Expert interviews and their insights on market shift, current and future outlook and factors impacting vendors short term and long term strategies
* Detailed insights on emerging regions, Type & End-user of molecule, and competitive landscape with qualitative and quantitative information and facts

Target Audience:
* Creatinine Measurement providers
* Traders, Importer and Exporter
* Raw material suppliers and distributors
* Research and consulting firms
* Government and research organizations
* Associations and industry bodies

Research Methodology

The market is derived through extensive use of secondary, primary, in-house research followed by expert validation and third party perspective like analyst report of investment banks. The secondary research forms the base of our study where we conducted extensive data mining, referring to verified data sources such as white papers government and regulatory published materials, technical journals, trade magazines, and paid data sources.

For forecasting, regional demand & supply factor, investment, market dynamics including technical scenario, consumer behavior, and end use industry trends and dynamics , capacity End-user of molecule, spending were taken into consideration.

We have assigned weights to these parameters and quantified their market impacts using the weighted average analysis to derive the expected market growth rate.

The market estimates and forecasts have been verified through exhaustive primary research with the Key Industry Participants (KIPs) which typically include:
* Original Equipment Manufacturer,
* Type Supplier,
* Distributors,
* Government Body & Associations, and
* Research Institute

TABLE OF CONTENT

1 EXECUTIVE SUMMARY

2 METHODOLOGY AND MARKET SCOPE
2.1 Research Methodology
2.2 Research Scope & Assumptions

3 CREATININE MEASUREMENT MARKET — INDUSTRY OUTLOOK
3.1 Market Segmentation and Scope
3.2 Market Size & Growth Prospects
3.3 Creatinine Measurement Market — Value Chain / Supply Chain Analysis
3.3.1 Company Landscape
3.4 Creatinine Measurement Market — Market Dynamics
3.4.1 Market Driver
3.4.2 Market Restraints
3.4.3 Market Challenges
3.5 Creatinine Measurement Market Company Market Share, 2017
3.6 Creatinine Measurement Market — Porter\'s Five Forces Analysis
3.7 Creatinine Measurement Market — Pestel Analysis

4 CREATININE MEASUREMENT MARKET TYPE OUTLOOK
4.1 Creatinine Measurement Market Share by Type, 2016 & 2025
4.2 Jaffe\'s kinetic method
4.3 Enzymatic method

5 CREATININE MEASUREMENT MARKET END-USER OF MOLECULE OUTLOOK
5.1 Creatinine Measurement Market Share by End-user of molecule, 2016 & 2025
5.2 Hospitals
5.3 Diagnostic laboratories

6 CREATININE MEASUREMENT MARKET REGIONAL OUTLOOK
6.1 Creatinine Measurement Market Share by Region, 2016 & 2025
6.2 North America
6.2.1 North America Creatinine Measurement Market, 2014 - 2025
6.2.2 North America Creatinine Measurement Market, By Type, 2014 - 2025
6.2.3 North America Creatinine Measurement Market, By End-user of molecule, 2014 - 2025
6.2.5 U.S.
6.2.5.1 U.S. Creatinine Measurement Market, By Type, 2014 - 2025
6.2.5.2 U.S. Creatinine Measurement Market, By End-user of molecule, 2014 - 2025
6.2.6 Canada
6.2.6.1 Canada Creatinine Measurement Market, By Type, 2014 - 2025
6.2.6.2 Canada Creatinine Measurement Market, By End-user of molecule, 2014 - 2025
6.3 Europe
6.3.1 Europe Creatinine Measurement Market, 2014 - 2025
6.3.2 Europe Creatinine Measurement Market, By Type, 2014 - 2025
6.3.3 Europe Creatinine Measurement Market, By End-user of molecule, 2014 - 2025
6.3.5 Germany
6.3.5.1 Germany Creatinine Measurement Market, By Type, 2014 - 2025
6.3.5.2 Germany Creatinine Measurement Market, By End-user of molecule, 2014 - 2025
6.3.6 UK
6.3.6.1 UK Creatinine Measurement Market, By Type, 2014 - 2025
6.3.6.2 UK Creatinine Measurement Market, By End-user of molecule, 2014 - 2025
6.4 Asia Pacific
6.4.1 Asia Pacific Creatinine Measurement Market, 2014 - 2025
6.4.2 Asia Pacific Creatinine Measurement Market, By Type, 2014 - 2025
6.4.3 Asia Pacific Creatinine Measurement Market, By End-user of molecule, 2014 - 2025
6.4.5 Australia
6.4.5.1 Australia Creatinine Measurement Market, By Type, 2014 - 2025
6.4.5.2 Australia Creatinine Measurement Market, By End-user of molecule, 2014 - 2025
6.4.6 New Zealand
6.4.6.1 New Zealand Creatinine Measurement Market, By Type, 2014 -
2025
6.4.6.2 New Zealand Creatinine Measurement Market, By End-user of molecule, 2014 -2025
6.4.7 China
6.4.7.1 China Creatinine Measurement Market, By Type, 2014 - 2025
6.4.7.2 China Creatinine Measurement Market, By End-user of molecule, 2014 - 2025
6.4.8 India
6.4.8.1 India Creatinine Measurement Market, By Type, 2014 - 2025
6.4.8.2 India Creatinine Measurement Market, By End-user of molecule, 2014 - 2025
6.4.9 Japan
6.4.9.1 Japan Creatinine Measurement Market, By Type, 2014 - 2025
6.4.9.2 Japan Creatinine Measurement Market, By End-user of molecule, 2014 - 2025
6.5 South America
6.5.1 South America Creatinine Measurement Market, 2014 - 2025
6.5.2 South America Creatinine Measurement Market, By Type, 2014 - 2025
6.5.3 South America Creatinine Measurement Market, By End-user of molecule, 2014 - 2025
6.5.5 Brazil
6.5.5.1 Brazil Creatinine Measurement Market, By Type, 2014 - 2025
6.5.5.2 Brazil Creatinine Measurement Market, By End-user of molecule, 2014 - 2025
6.5.6 Mexico
6.5.6.1 Mexico Creatinine Measurement Market, By Type, 2014 - 2025
6.5.6.2 Mexico Creatinine Measurement Market, By End-user of molecule, 2014 - 2025
6.6 MEA
6.6.1 MEA Creatinine Measurement Market, 2014 - 2025
6.6.2 MEA Creatinine Measurement Market, By Type, 2014 - 2025
6.6.3 MEA Creatinine Measurement Market, By End-user of molecule, 2014 - 2025

7 COMPETITIVE LANDSCAPE
7.1 F. Hoffmann-la Roche Ltd
7.1.1 Company overview
7.1.2 Financial performance
7.1.3 Type benchmarking
7.1.4 Strategic initiatives
7.2 Thermo Fisher Scientific Inc
7.2.1 Company overview
7.2.2 Financial performance
7.2.3 Type benchmarking
7.2.4 Strategic initiatives
7.3 Randox Laboratories
7.3.1 Company overview
7.3.2 Financial performance
7.3.3 Type benchmarking
7.3.4 Strategic initiatives
7.4 Abbott Laboratories
7.4.1 Company overview
7.4.2 Financial performance
7.4.3 Type benchmarking
7.4.4 Strategic initiatives
7.5 Siemens Healthineers
7.5.1 Company overview
7.5.2 Financial performance
7.5.3 Type benchmarking
7.5.4 Strategic initiatives

End of the report
Disclaimer

Content are not available

Choose License Type